Covalent flexible peptide docking in Rosetta. Issue 32 (19th July 2021)

• Record Type: Journal Article
• Authors: Tivon, Barr; Gabizon, Ronen; Somsen, Bente A.; Cossar, Peter J.; Ottmann, Christian; London, Nir
• Is Part Of: Chemical science. Volume 12:Issue 32(2021)
• Page Start: 10836
• Page End: 10847
• Publication Date: 2021-07-19
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/d1sc02322e
• Languages: English
• ISSNs: 2041-6520

Abstract

Abstract : We developed Rosetta CovPepDock, a computational pipeline for covalent peptide docking. We showed it is highly accurate in retrospective benchmarks, and applied it prospectively to design potent and selective covalent binders of 14-3-3σ. Abstract : Electrophilic peptides that form an irreversible covalent bond with their target have great potential for binding targets that have been previously considered undruggable. However, the discovery of such peptides remains a challenge. Here, we present Rosetta CovPepDock, a computational pipeline for peptide docking that incorporates covalent binding between the peptide and a receptor cysteine. We applied CovPepDock retrospectively to a dataset of 115 disulfide-bound peptides and a dataset of 54 electrophilic peptides. It produced a top-five scoring, near-native model, in 89% and 100% of the cases when docking from the native conformation, and 20% and 90% when docking from an extended peptide conformation, respectively. In addition, we developed a protocol for designing electrophilic peptide binders based on known non-covalent binders or protein–protein interfaces. We identified 7154 peptide candidates in the PDB for application of this protocol. As a proof-of-concept we validated the protocol on the non-covalent complex of 14-3-3σ and YAP1 phosphopeptide. The protocol identified seven highly potent and selective irreversible peptide binders. The predicted binding mode of one of the peptides was validated using X-ray crystallography. This case-study demonstrates the utility and impact of CovPepDock. It suggests that many new electrophilic peptide binders can be rapidly discovered, with significant potential as therapeutic molecules and chemical probes.